Single-dose vaccine delivers protection against cervical cancer-causing HPV comparable to 2 or 3-dose regimes

By | April 14, 2022
A recent report suggested that a single dose of the human papillomavirus (HPV) vaccination confers equivalent immunity to a two-dose schedule against cervical cancers caused by HPV.